Updates

Joe Grogan’s recent op-ed, “How America Can Defuse the Alzheimer’s Economic Bomb,” argues that rising rates of Alzheimer’s disease threaten to overwhelm the U.S. economy by pushing more patients into costly long-term care, reducing workforce participation, and accelerating the insolvency of Social Security and entitlement programs. He calls on U.S. policymakers to make Alzheimer’s a national priority by expanding Medicare coverage for early detection tests, removing regulatory barriers to treatment, and embedding cognitive-health strategies into routine care.

John Czwartacki’s recent op-ed “To make America Healthy Again, Fight Alzheimer’s” argues that efforts to “Make America Healthy Again” should focus on fighting Alzheimer’s disease. He emphasizes that early diagnosis, timely treatments, and expanded research are essential because the toll of Alzheimer’s on patients, families, and society continues to grow. He cautions that delays in diagnosis waste valuable time, when intervention could slow disease progression and help Americans stay healthier longer. 

Experts with Public Policy Solutions have deemed the EU’s administration of its digital regulations as a form of protectionism, but Lutnick argued that the EU and United States would mutually benefit from the EU easing up on its digital regulations, which disproportionately impact American companies.

In his recent op-ed, “How to connect America’s heartland and fix Biden’s mess,” John Czwartacki argues that the Broadband Equality, Access and Deployment (BEAD) Program, intended to bridge the digital divide in rural America, has become a bureaucratic burden filled with politically motivated requirements, leaving much of the $42 billion unspent. 

“Maybe the Democrats would have been more reluctant to shut the government down for a political stunt if they were forced to live like Americans who couldn’t get food stamps, or had their flights cancelled, or didn’t get paid for their work in a federal agency,” Grogan, who oversaw domestic healthcare spending of $1.3 trillion in the last Trump administration, told the Post.

Joe Grogan’s latest op-ed, “Trump’s congressional allies finally move on 340B,” highlights how congressional allies of President Trump are advancing long-awaited reforms to the federal 340B Drug Discount Program, which was designated to help hospitals serve low-income patients but has since ballooned into a system critics say benefits large health systems instead.